BIOFILCHEM — Biofil Chemicals and Pharmaceuticals Share Price
Last trade - 00:00- IN₹1.10bn
- IN₹1.11bn
- IN₹300.35m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.23 | ||
| Price to Tang. Book | 6.23 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.87 | ||
| EV to EBITDA | 87.83 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.6% | ||
| Return on Equity | 3.85% | ||
| Operating Margin | 2.16% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 231.28 | 296.9 | 357.5 | 223.82 | 300.35 | n/a | n/a | 19.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +2.47 | +150.3 | +2.83 | -43.74 | -19.76 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biofil Chemicals and Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing and trading pharmaceutical products. The Company operates through two segments: the Pharmaceutical Division and the Chemicals Division. It is also involved in the business activity of producing plastic products, which are used for the purpose of packing pharmaceutical product and other plastic products. The Company’s product categories include Basic Drugs & Chemicals, and Plastic Dripper & Caps. Its Basic Drugs & Chemicals include Sodium Chloride, Potassium Chloride, Sodium Citrate, Diethyl Carbamazine Citrate, Ferrous Sulphate, Dried Ferrous Sulphate, Ferrus Fumerate, Micro Crystalline Cellulose and Dicyclomine Hydrochloride. The Company's plants are located at Kheda Industrial Estate, Pithampur District, Dhar, and Sanwer Road, Industrial Area, Indore in Madhya Pradesh. The Company also deals in providing job work facilities in respect of the manufacturing of pharmaceutical drugs.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 4th, 1985
- Public Since
- October 25th, 1993
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 16,273,800
- Address
- 11/12 Sector E Sanwer Road, INDORE, 452015
- Web
- https://www.biofilgroup.net/
- Phone
- +91 7312426700
- Auditors
- Maheshwari & Gupta Chartered Accountants
Upcoming Events for BIOFILCHEM
Similar to BIOFILCHEM
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 19:04 UTC, shares in Biofil Chemicals and Pharmaceuticals are trading at IN₹67.70. This share price information is delayed by 15 minutes.
Shares in Biofil Chemicals and Pharmaceuticals last closed at IN₹67.70 and the price had moved by +51.96% over the past 365 days. In terms of relative price strength the Biofil Chemicals and Pharmaceuticals share price has outperformed the S&P BSE 100 Index by +15.17% over the past year.
There is no consensus recommendation for this security.
Biofil Chemicals and Pharmaceuticals does not currently pay a dividend.
Biofil Chemicals and Pharmaceuticals does not currently pay a dividend.
Biofil Chemicals and Pharmaceuticals does not currently pay a dividend.
To buy shares in Biofil Chemicals and Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹67.70, shares in Biofil Chemicals and Pharmaceuticals had a market capitalisation of IN₹1.10bn.
Here are the trading details for Biofil Chemicals and Pharmaceuticals:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: BIOFILCHEM
Based on an overall assessment of its quality, value and momentum Biofil Chemicals and Pharmaceuticals is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biofil Chemicals and Pharmaceuticals. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +13.45%.
As of the last closing price of IN₹67.70, shares in Biofil Chemicals and Pharmaceuticals were trading +25.03% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Biofil Chemicals and Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹67.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Biofil Chemicals and Pharmaceuticals' directors